| PDF - Published Version (2MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-338844
- DOI to cite this document:
- 10.5283/epub.33884
Abstract
Patients with malignant gliomas have a poor prognosis with average survival of less than 1 year. Whereas in other tumor entities the characteristics of tumor metabolism are successfully used for therapeutic approaches, such developments are very rare in brain tumors, notably in gliomas. One metabolic feature characteristic of gliomas, in particular diffuse astrocytomas and oligodendroglial ...

Owner only: item control page


Download Statistics